Last reviewed · How we verify
NCT05342090: PoRS
Postoperative Return to Sexual Activity
NA trial testing Structured Counselling Tool in Sexual Function Disturbances in 186 participants. Completed in 29 February 2024.
29 February 2024
Quick facts
| Lead sponsor | University of Calgary |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 186 |
| Start date | 5 April 2022 |
| Primary completion | 29 February 2024 |
| Estimated completion | 29 February 2024 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Structured Counselling Tool
Conditions studied
- Sexual Function Disturbances — all drugs for Sexual Function Disturbances →
- Pelvic Organ Prolapse — all drugs for Pelvic Organ Prolapse →
- Stress Urinary Incontinence — all drugs for Stress Urinary Incontinence →
- Surgery — all drugs for Surgery →
Sponsor
University of Calgary
Who can join
18 and older, female only, with Sexual Function Disturbances or Pelvic Organ Prolapse. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To determine if standardized counselling regarding first sexual encounter after pelvic reconstructive surgery for pelvic organ prolapse and / or urinary incontinence improves postoperative preparedness to return to sexual activity and sexual function.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Intervention Counseling for Return to Sex After Urogynecologic Surgery: A Randomized Controlled Trial.
Kim-Fine S, Caldwell L, Long J, Meriwether KV, et al · · 2025 · PMID 40934518 · DOI 10.1097/aog.0000000000006064
Verify or expand the search:
- PubMed search for NCT05342090
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sexual Function Disturbances
Currently open trials in the same condition.
- NCT06458049 — Sexual Health and Rehabilitation Online (SHAREonline) · NA · active not recruiting
- NCT06017128 — Sexual Counseling's Impact on Hip Replacement Patients' Sexual Function and Quality of Life: a PLISSIT Model Study · NA · active not recruiting
- NCT06028009 — PRP Injections for Genitourinary Syndrome of Menopause · NA · active not recruiting
- NCT05698576 — TRANBERG® Transperineal MR/US Fusion Laser--Induced Thermal Therapy for Men With Prostate Cancer · NA · recruiting
Other University of Calgary trials
Trials by the same sponsor.
- NCT06885996 — Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner Violence · Phase 2 · not yet recruiting
- NCT05729503 — Effect of SPG Block for Patients With Anxiety at Electronic Dance Music Festivals · Phase 2 · not yet recruiting
- NCT07463339 — Microbiome-guided Prophylaxis to Reduce Ventilator-Associated Pneumonia in Intensive Care Units: A Pilot Randomized Cont · Phase 2 · not yet recruiting
- NCT07145645 — Topical Diclofenac vs.Oral Ibuprofen for MSK Pain in Children · Phase 3 · recruiting
- NCT07280325 — Moxie Self-Management and Education Support Program · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05342090 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Calgary
- Last refreshed: 2 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05342090.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing